Evidence map›Paper›PMID 39585215›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years.

Jessica Chubak, Laura E Ichikawa, Sophie A Merchant, Ronit R Dalmat, Rebecca A Ziebell, Christopher D Jensen, Jeffrey K Lee, Douglas A Corley, Nirupa R Ghai, Beverly B Green and 4 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Outcomes of Screening Colonoscopy in Older Adults: A Large Propensity-Matched Real-World Cohort Study.JGH open : an open access journal of gastroenterology and hepatology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Adverse Events After Surveillance Colonoscopy in Older Adults in a Large Integrated Health System in the United States.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jessica ChubakKaiser Permanente Washington Health Research Institute, Seattle, Washington.ORCID 0000-0003-1630-9021
Laura E IchikawaKaiser Permanente Washington Health Research Institute, Seattle, Washington.ORCID 0000-0002-0882-6662
Sophie A MerchantDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0003-0479-9887
Ronit R DalmatDepartment of Global Health, University of Washington, Seattle, Washington.ORCID 0000-0002-6959-0817
Rebecca A ZiebellKaiser Permanente Washington Health Research Institute, Seattle, Washington.ORCID 0000-0002-4255-7785
Christopher D JensenDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0001-8001-1284
Jeffrey K LeeDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0001-7404-4274
Douglas A CorleyDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0001-6132-5165
Nirupa R GhaiDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.ORCID 0009-0008-3064-7434
Beverly B GreenKaiser Permanente Washington Health Research Institute, Seattle, Washington.ORCID 0000-0003-3040-3436
Celette Sugg SkinnerSimmons Comprehensive Cancer Center and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-2535-4476
Joanne E SchottingerDepartment of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.ORCID 0000-0002-8276-7672
Erica S BreslauDivision of Cancer Prevention and Control, National Cancer Institute, Rockville, Maryland.ORCID 0000-0001-6391-6305
Theodore R LevinDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0002-0842-2377

Funding

Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)UM1CA222035 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA, CORLEY, DOUGLAS ALLEN · 2018 to 2023
$15.6M
National Institutes of Health (NIH) UM1CA222035NCI NIH HHS UM1 CA222035
6 · The paper itself

Abstract

backgroundScreening colonoscopy harm data are limited for adults ages 76 to 85 years.

methodsWe conducted a retrospective cohort study of screening colonoscopies versus fecal immunochemical tests (FIT) and general population matched comparators ages 76 to 85 years within three integrated healthcare systems (2010-2019). The primary outcome was death or overnight hospitalization within 30 days. A secondary outcome also included nine harm diagnoses. Adjusted risk estimates and risk differences (RD) were obtained using Poisson regression. Narrow analyses excluded outcomes after the next lower endoscopy or colorectal procedure, whereas broad analyses included them.

resultsPatients undergoing screening colonoscopy (N = 4,435) had a higher 10-day cumulative incidence of gastrointestinal bleeding {0.18% [95% confidence interval (CI), 0.09%-0.35%]} and perforation [0.09% (95% CI, 0.03%-0.23%)] than those with FIT (N = 17,740) and the general population (N = 44,350) in the narrow analysis. Screening colonoscopy patients had a 1.04% (95% CI, 0.74%-1.34%) risk of death or hospitalization within 30 days in the narrow analysis, similar to those with FIT [RD = 0% (95% CI, -0.36% to 0.35%)] and the general population [RD = -0.07% (95% CI, -0.39% to 0.25%)]. In the broad analysis, risk following colonoscopy was 2.30% (95% CI, 1.85%-2.75%) with RD = 1.13% (95% CI, 0.67%-1.60%) versus general population [ages 76-80 years: RD = 0.93% (95% CI, 0.45%-1.41%) and ages 81-85 years: RD = 2.14% (95% CI, 0.74%-3.54%)]. Secondary outcomes followed a similar pattern by age.

conclusionsAt ages 76 to 85 years, screening colonoscopies including downstream procedures are associated with an increased short-term risk of death or hospitalization. IMPACT: Harm data can be combined with benefit data to guide screening colonoscopy decisions among older adults.

Indexed as

ColonoscopyColorectal NeoplasmsEarly Detection of CancerGastrointestinal HemorrhageAgedAged, 80 and overFemaleHumansIncidenceMaleRetrospective Studies

Identifiers

PMID39585215
PMCPMC11802309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.